Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 337 to 347 of 347 entries
Sorted by: Best Match Show Resources per page
The Role of The Gut Microbiome in Parkinson's Disease.

Journal of geriatric psychiatry and neurology

Gallop A, Weagley J, Paracha SU, Grossberg G.
PMID: 34219519
J Geriatr Psychiatry Neurol. 2021 Jul;34(4):253-262. doi: 10.1177/08919887211018268.

The gut microbiota is known to play a role in various disease states through inflammatory, immune and endocrinologic response. Parkinson's Disease is of particular interest as gastrointestinal involvement is one of the earlier features seen in this disease. This...

Cite
Gallop A, Weagley J, Paracha SU, et al. The Role of The Gut Microbiome in Parkinson's Disease. J Geriatr Psychiatry Neurol. 2021;34(4):253-262doi: 10.1177/08919887211018268.
Gallop, A., Weagley, J., Paracha, S. U., & Grossberg, G. (2021). The Role of The Gut Microbiome in Parkinson's Disease. Journal of geriatric psychiatry and neurology, 34(4), 253-262. https://doi.org/10.1177/08919887211018268
Gallop, Amy, et al. "The Role of The Gut Microbiome in Parkinson's Disease." Journal of geriatric psychiatry and neurology vol. 34,4 (2021): 253-262. doi: https://doi.org/10.1177/08919887211018268
Gallop A, Weagley J, Paracha SU, Grossberg G. The Role of The Gut Microbiome in Parkinson's Disease. J Geriatr Psychiatry Neurol. 2021 Jul;34(4):253-262. doi: 10.1177/08919887211018268. PMID: 34219519.
Copy Download .nbib Format: NLM
Drugs, bugs, and MS: The interplay between disease-modifying therapy and gut microbiota.

Neurology(R) neuroimmunology & neuroinflammation

Mangalam AK.
PMID: 30569001
Neurol Neuroimmunol Neuroinflamm. 2018 Nov 27;6(1):e524. doi: 10.1212/NXI.0000000000000524. eCollection 2019 Jan.

No abstract available.

Cite
Mangalam AK. Drugs, bugs, and MS: The interplay between disease-modifying therapy and gut microbiota. Neurol Neuroimmunol Neuroinflamm. 2018;6(1):e524doi: 10.1212/NXI.0000000000000524.
Mangalam, A. K. (2019). Drugs, bugs, and MS: The interplay between disease-modifying therapy and gut microbiota. Neurology(R) neuroimmunology & neuroinflammation, 6(1), e524. https://doi.org/10.1212/NXI.0000000000000524
Mangalam, Ashutosh K. "Drugs, bugs, and MS: The interplay between disease-modifying therapy and gut microbiota." Neurology(R) neuroimmunology & neuroinflammation vol. 6,1 (2019): e524. doi: https://doi.org/10.1212/NXI.0000000000000524
Mangalam AK. Drugs, bugs, and MS: The interplay between disease-modifying therapy and gut microbiota. Neurol Neuroimmunol Neuroinflamm. 2018 Nov 27;6(1):e524. doi: 10.1212/NXI.0000000000000524. eCollection 2019 Jan. PMID: 30569001; PMCID: PMC6278853.
Copy Download .nbib Format: NLM
Benefits of Iterative Searches of Large Databases to Interpret Large Human Gut Metaproteomic Data Sets.

Journal of proteome research

Bassignani A, Plancade S, Berland M, Blein-Nicolas M, Guillot A, Chevret D, Moritz C, Huet S, Rizkalla S, Clément K, Doré J, Langella O, Juste C.
PMID: 33528260
J Proteome Res. 2021 Mar 05;20(3):1522-1534. doi: 10.1021/acs.jproteome.0c00669. Epub 2021 Feb 02.

The gut microbiota are increasingly considered as a main partner of human health. Metaproteomics enables us to move from the functional potential revealed by metagenomics to the functions actually operating in the microbiome. However, metaproteome deciphering remains challenging. In...

Cite
Bassignani A, Plancade S, Berland M, et al. Benefits of Iterative Searches of Large Databases to Interpret Large Human Gut Metaproteomic Data Sets. J Proteome Res. 2021;20(3):1522-1534doi: 10.1021/acs.jproteome.0c00669.
Bassignani, A., Plancade, S., Berland, M., Blein-Nicolas, M., Guillot, A., Chevret, D., Moritz, C., Huet, S., Rizkalla, S., Clément, K., Doré, J., Langella, O., & Juste, C. (2021). Benefits of Iterative Searches of Large Databases to Interpret Large Human Gut Metaproteomic Data Sets. Journal of proteome research, 20(3), 1522-1534. https://doi.org/10.1021/acs.jproteome.0c00669
Bassignani, Ariane, et al. "Benefits of Iterative Searches of Large Databases to Interpret Large Human Gut Metaproteomic Data Sets." Journal of proteome research vol. 20,3 (2021): 1522-1534. doi: https://doi.org/10.1021/acs.jproteome.0c00669
Bassignani A, Plancade S, Berland M, Blein-Nicolas M, Guillot A, Chevret D, Moritz C, Huet S, Rizkalla S, Clément K, Doré J, Langella O, Juste C. Benefits of Iterative Searches of Large Databases to Interpret Large Human Gut Metaproteomic Data Sets. J Proteome Res. 2021 Mar 05;20(3):1522-1534. doi: 10.1021/acs.jproteome.0c00669. Epub 2021 Feb 02. PMID: 33528260.
Copy Download .nbib Format: NLM
Dieting for Success: What Baseline Gut Microbiota Can Tell You About Your Chances of Losing Weight.

Gastroenterology

Reimer RA, Delzenne NM.
PMID: 33581120
Gastroenterology. 2021 May;160(6):1933-1935. doi: 10.1053/j.gastro.2021.02.021. Epub 2021 Feb 11.

No abstract available.

Cite
Reimer RA, Delzenne NM. Dieting for Success: What Baseline Gut Microbiota Can Tell You About Your Chances of Losing Weight. Gastroenterology. 2021;160(6):1933-1935doi: 10.1053/j.gastro.2021.02.021.
Reimer, R. A., & Delzenne, N. M. (2021). Dieting for Success: What Baseline Gut Microbiota Can Tell You About Your Chances of Losing Weight. Gastroenterology, 160(6), 1933-1935. https://doi.org/10.1053/j.gastro.2021.02.021
Reimer, Raylene A, and Delzenne, Nathalie M. "Dieting for Success: What Baseline Gut Microbiota Can Tell You About Your Chances of Losing Weight." Gastroenterology vol. 160,6 (2021): 1933-1935. doi: https://doi.org/10.1053/j.gastro.2021.02.021
Reimer RA, Delzenne NM. Dieting for Success: What Baseline Gut Microbiota Can Tell You About Your Chances of Losing Weight. Gastroenterology. 2021 May;160(6):1933-1935. doi: 10.1053/j.gastro.2021.02.021. Epub 2021 Feb 11. PMID: 33581120.
Copy Download .nbib Format: NLM
Impact of COVID-19 on the Intestinal Microbiome.

Current nutrition reports

Venegas-Borsellino C, Sankararaman S, Roche K, Burns J, Landis RM.
PMID: 34813042
Curr Nutr Rep. 2021 Dec;10(4):300-306. doi: 10.1007/s13668-021-00375-z. Epub 2021 Nov 23.

PURPOSE OF REVIEW: This review article aims to explore the GI changes induced by SARS-CoV-2 and how gut microbial homeostasis can influence these changes and affect the lung-gut axis and its relationship with the induction of the cytokine release...

Cite
Venegas-Borsellino C, Sankararaman S, Roche K, et al. Impact of COVID-19 on the Intestinal Microbiome. Curr Nutr Rep. 2021;10(4):300-306doi: 10.1007/s13668-021-00375-z.
Venegas-Borsellino, C., Sankararaman, S., Roche, K., Burns, J., & Landis, R. M. (2021). Impact of COVID-19 on the Intestinal Microbiome. Current nutrition reports, 10(4), 300-306. https://doi.org/10.1007/s13668-021-00375-z
Venegas-Borsellino, Carla, et al. "Impact of COVID-19 on the Intestinal Microbiome." Current nutrition reports vol. 10,4 (2021): 300-306. doi: https://doi.org/10.1007/s13668-021-00375-z
Venegas-Borsellino C, Sankararaman S, Roche K, Burns J, Landis RM. Impact of COVID-19 on the Intestinal Microbiome. Curr Nutr Rep. 2021 Dec;10(4):300-306. doi: 10.1007/s13668-021-00375-z. Epub 2021 Nov 23. PMID: 34813042; PMCID: PMC8609508.
Copy Download .nbib Format: NLM
Lower Airway Dysbiosis Exacerbates Lung Cancer.

Cancer discovery

Zitvogel L, Kroemer G.
PMID: 33531424
Cancer Discov. 2021 Feb;11(2):224-226. doi: 10.1158/2159-8290.CD-20-1641.

Accumulating evidence supports the impact of the gut microbiota on the clinical efficacy of cancer immunotherapies against extraintestinal tumors, but it has not yet been addressed whether local commensals could also dictate the prognosis of patients with cancer. In...

Cite
Zitvogel L, Kroemer G. Lower Airway Dysbiosis Exacerbates Lung Cancer. Cancer Discov. 2021;11(2):224-226doi: 10.1158/2159-8290.CD-20-1641.
Zitvogel, L., & Kroemer, G. (2021). Lower Airway Dysbiosis Exacerbates Lung Cancer. Cancer discovery, 11(2), 224-226. https://doi.org/10.1158/2159-8290.CD-20-1641
Zitvogel, Laurence, and Kroemer, Guido. "Lower Airway Dysbiosis Exacerbates Lung Cancer." Cancer discovery vol. 11,2 (2021): 224-226. doi: https://doi.org/10.1158/2159-8290.CD-20-1641
Zitvogel L, Kroemer G. Lower Airway Dysbiosis Exacerbates Lung Cancer. Cancer Discov. 2021 Feb;11(2):224-226. doi: 10.1158/2159-8290.CD-20-1641. PMID: 33531424.
Copy Download .nbib Format: NLM
Alterations in the Composition of Intestinal DNA Virome in Patients With COVID-19.

Frontiers in cellular and infection microbiology

Lu ZH, Zhou HW, Wu WK, Fu T, Yan M, He Z, Sun SW, Ji ZH, Shao ZJ.
PMID: 34900762
Front Cell Infect Microbiol. 2021 Nov 24;11:790422. doi: 10.3389/fcimb.2021.790422. eCollection 2021.

Patients with Coronavirus Disease 2019 (COVID-19), due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection mainly present with respiratory issues and related symptoms, in addition to significantly affected digestive system, especially the intestinal tract. While several studies have...

Cite
Lu ZH, Zhou HW, Wu WK, et al. Alterations in the Composition of Intestinal DNA Virome in Patients With COVID-19. Front Cell Infect Microbiol. 2021;11:790422doi: 10.3389/fcimb.2021.790422.
Lu, Z. H., Zhou, H. W., Wu, W. K., Fu, T., Yan, M., He, Z., Sun, S. W., Ji, Z. H., & Shao, Z. J. (2021). Alterations in the Composition of Intestinal DNA Virome in Patients With COVID-19. Frontiers in cellular and infection microbiology, 11790422. https://doi.org/10.3389/fcimb.2021.790422
Lu, Zhen-Hua, et al. "Alterations in the Composition of Intestinal DNA Virome in Patients With COVID-19." Frontiers in cellular and infection microbiology vol. 11 (2021): 790422. doi: https://doi.org/10.3389/fcimb.2021.790422
Lu ZH, Zhou HW, Wu WK, Fu T, Yan M, He Z, Sun SW, Ji ZH, Shao ZJ. Alterations in the Composition of Intestinal DNA Virome in Patients With COVID-19. Front Cell Infect Microbiol. 2021 Nov 24;11:790422. doi: 10.3389/fcimb.2021.790422. eCollection 2021. PMID: 34900762; PMCID: PMC8653907.
Copy Download .nbib Format: NLM
Special Issue on Gut Pathogens.

ACS infectious diseases

Van Voorhis WC, Calderón F.
PMID: 33938729
ACS Infect Dis. 2021 May 14;7(5):938. doi: 10.1021/acsinfecdis.1c00214. Epub 2021 May 03.

No abstract available.

Cite
Van Voorhis WC, Calderón F. Special Issue on Gut Pathogens. ACS Infect Dis. 2021;7(5):938doi: 10.1021/acsinfecdis.1c00214.
Van Voorhis, W. C., & Calderón, F. (2021). Special Issue on Gut Pathogens. ACS infectious diseases, 7(5), 938. https://doi.org/10.1021/acsinfecdis.1c00214
Van Voorhis, Wesley C, and Calderón, Felix. "Special Issue on Gut Pathogens." ACS infectious diseases vol. 7,5 (2021): 938. doi: https://doi.org/10.1021/acsinfecdis.1c00214
Van Voorhis WC, Calderón F. Special Issue on Gut Pathogens. ACS Infect Dis. 2021 May 14;7(5):938. doi: 10.1021/acsinfecdis.1c00214. Epub 2021 May 03. PMID: 33938729.
Copy Download .nbib Format: NLM
New Tricks for Old Friends: Treating Gut Microbiota of Patients With CKD.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation

Mafra D, Kalantar-Zadeh K, Moore LW.
PMID: 34294553
J Ren Nutr. 2021 Sep;31(5):433-437. doi: 10.1053/j.jrn.2021.07.002. Epub 2021 Jul 20.

No abstract available.

Cite
Mafra D, Kalantar-Zadeh K, Moore LW. New Tricks for Old Friends: Treating Gut Microbiota of Patients With CKD. J Ren Nutr. 2021;31(5):433-437doi: 10.1053/j.jrn.2021.07.002.
Mafra, D., Kalantar-Zadeh, K., & Moore, L. W. (2021). New Tricks for Old Friends: Treating Gut Microbiota of Patients With CKD. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 31(5), 433-437. https://doi.org/10.1053/j.jrn.2021.07.002
Mafra, Denise, et al. "New Tricks for Old Friends: Treating Gut Microbiota of Patients With CKD." Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation vol. 31,5 (2021): 433-437. doi: https://doi.org/10.1053/j.jrn.2021.07.002
Mafra D, Kalantar-Zadeh K, Moore LW. New Tricks for Old Friends: Treating Gut Microbiota of Patients With CKD. J Ren Nutr. 2021 Sep;31(5):433-437. doi: 10.1053/j.jrn.2021.07.002. Epub 2021 Jul 20. PMID: 34294553.
Copy Download .nbib Format: NLM
HumGut: a comprehensive human gut prokaryotic genomes collection filtered by metagenome data.

Microbiome

Hiseni P, Rudi K, Wilson RC, Hegge FT, Snipen L.
PMID: 34330336
Microbiome. 2021 Jul 31;9(1):165. doi: 10.1186/s40168-021-01114-w.

BACKGROUND: A major bottleneck in the use of metagenome sequencing for human gut microbiome studies has been the lack of a comprehensive genome collection to be used as a reference database. Several recent efforts have been made to re-construct...

Cite
Hiseni P, Rudi K, Wilson RC, et al. HumGut: a comprehensive human gut prokaryotic genomes collection filtered by metagenome data. Microbiome. 2021;9(1):165doi: 10.1186/s40168-021-01114-w.
Hiseni, P., Rudi, K., Wilson, R. C., Hegge, F. T., & Snipen, L. (2021). HumGut: a comprehensive human gut prokaryotic genomes collection filtered by metagenome data. Microbiome, 9(1), 165. https://doi.org/10.1186/s40168-021-01114-w
Hiseni, Pranvera, et al. "HumGut: a comprehensive human gut prokaryotic genomes collection filtered by metagenome data." Microbiome vol. 9,1 (2021): 165. doi: https://doi.org/10.1186/s40168-021-01114-w
Hiseni P, Rudi K, Wilson RC, Hegge FT, Snipen L. HumGut: a comprehensive human gut prokaryotic genomes collection filtered by metagenome data. Microbiome. 2021 Jul 31;9(1):165. doi: 10.1186/s40168-021-01114-w. PMID: 34330336; PMCID: PMC8325300.
Copy Download .nbib Format: NLM
Coronavirus disease 2019 and the gut-lung axis.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Zhou D, Wang Q, Liu H.
PMID: 34517046
Int J Infect Dis. 2021 Dec;113:300-307. doi: 10.1016/j.ijid.2021.09.013. Epub 2021 Sep 10.

Gastrointestinal and respiratory tract diseases often occur together. There are many overlapping pathologies, leading to the concept of the 'gut-lung axis' in which stimulation on one side triggers a response on the other side. This axis appears to be...

Cite
Zhou D, Wang Q, Liu H. Coronavirus disease 2019 and the gut-lung axis. Int J Infect Dis. 2021;113:300-307doi: 10.1016/j.ijid.2021.09.013.
Zhou, D., Wang, Q., & Liu, H. (2021). Coronavirus disease 2019 and the gut-lung axis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 113300-307. https://doi.org/10.1016/j.ijid.2021.09.013
Zhou, Dan, et al. "Coronavirus disease 2019 and the gut-lung axis." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. 113 (2021): 300-307. doi: https://doi.org/10.1016/j.ijid.2021.09.013
Zhou D, Wang Q, Liu H. Coronavirus disease 2019 and the gut-lung axis. Int J Infect Dis. 2021 Dec;113:300-307. doi: 10.1016/j.ijid.2021.09.013. Epub 2021 Sep 10. PMID: 34517046; PMCID: PMC8431834.
Copy Download .nbib Format: NLM
Showing 337 to 347 of 347 entries